Panteha Torabian

The paper shows that bacterial extracellular vesicles disrupt a BBB on-chip model indirectly via immune cell activation, not directly through BMEC damage.

This study shows antibiotic treatment affects BEV production and their ability to upregulate ICAM-1 in endothelial cells, with meropenem increasing BEV production and stimulatory capacity in E. coli strains.

This study examines how clinically relevant antibiotics affect extracellular vesicle release from E. coli, finding that beta-lactams increase release while quinolones and aminoglycosides decrease it.